Abstract
This study aimed at deriving a preference valuation set for EQ-5D health states from the general Flemish public in Belgium. A EuroQol valuation instrument with 16 health states to be valued on a visual analogue scale was sent to a random sample of 2,754 adults. The initial response rate was 35%. Eventually, 548 (20%) respondents provided useable valuations for modeling. Valuations for 245 health states were modeled using a random effects model. The selection of the model was based on two criteria: health state valuations must be consistent, and the difference with the directly observed valuations must be small. A model including a value decrement if any health dimension of the EQ-5D is on the worst level was selected to construct the social health state valuation set. A comparison with health state valuations from other countries showed similarities, especially with those from New Zealand. The use of a single preference valuation set across different health economic evaluations within a country is highly preferable to increase their usability for policy makers. This study contributes to the standardization of outcome measurement in economic evaluations in Belgium.
Similar content being viewed by others
References
Dolan, P.: Modeling valuations for EuroQol health states. Med Care 35, 1095–1108 (1997)
MVH Group: The measurement and valuation of health. Final report on the modelling of valuation tariffs. York Centre for Health Economics (1995)
Greiner, W., Claes, C., van Busschbach, J., Graf von der Schulenburg, J.: Validating the EQ-5D with time trade off for the German population. Eur J Health Econ 6, 124–130 (2005)
Tsuchiya, A., Ikeda, S., Ikegami, N., Nishimura, S., Sakai, I., Fukuda, T., Hamashima, C., Hisashige, A., Tamura, M.: Estimating an EQ-5D population value set: the case of Japan. Health Econ 11, 341–353 (2002)
Wittrup-Jensen, K.U., Lauridsen, J.T., Gudex, C., Brooks, R., Pedersen, K.M.: Estimating Danish EQ-5D tariffs using TTO and VAS. In: Norinder, A., Pedersen, K., Roos, P. (eds.) 18th Plenary Meeting of the EuroQol Group, pp. 257–92. IHE, The Swedish Institute for Health Economics (2002)
Lamers, L.M., McDonnell, J., Stalmeier, P., Krabbe, P., Busschbach, J.: The Dutch Tariff: results and arguments for an effective design for national EQ-5D valuation studies. Health Econ 15, 1121–1132 (2006)
Shaw, J.W., Johnson, J.A., Coons, S.J.: US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care 43, 203–220 (2005)
Jelsma, J., Hansen, K., De Weerdt, W., De Cock, P., Kind, P.: How do Zimbabweans value health states? Popul Health Metrics 1, 11 (2003)
Badia, X., Roset, M., Herdman, M., Kind, P.: A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states. Med Decis Making 21, 7–16 (2001)
Claes, C., Greiner, W., Uber, A., Graf von der Schulenburg, J.: An interview-based comparison of the TTO and VAS values given to EuroQol states of health by the general German population. In: Greiner, W., Graf von der Schulenburg, J., Piercy, J. (eds.) EQ Plenary Meeting. Hannover (1999)
Ohinmaa, A., Eija, H., Sintonen, H.: Modelling EuroQol values of Finnish adult population. In: Badia, X., Herdman, M., Segura, A., (eds.) EuroQol Plenary Meeting. Barcelona. Institut Universitari de Salut Publica de Catalunya (1995)
Ohinmaa, A., Sintonen, H.: Inconsistencies and modelling of the Finnish EuroQol (EQ-5D) preference values. Paper presented tot the 15th EuroQol Plenary Meeting, Hanover (1998)
Devlin, N.J., Hansen, P., Kind, P., Williams, A.: Logical inconsistencies in survey respondents’ health state valuations—a methodological challenge for estimating social tariffs. Health Econ 12, 529–544 (2003)
Prevolnik Rupel, V., Rebolj, M.: The Slovenian VAS Tariff based on valuations of EQ-5D health states from the general population. In: Cabasés, J.M., Gaminde, I. (eds.) 17th Plenary Meeting of the EuroQol Group, pp. 23–47. Universidad Pública de Navarra (2001)
Badia, X., Roset, M., Monserrat, S., Herdman, M.: The Spanish VAS tariff based on valuations of EQ-5D health states from the general population. Proceedings of the EuroQol Plenary Meeting, Rotterdam (1997)
Greiner, W., Weijnen, T., Nieuwenhuizen, M., Oppe, S., Badia, X., Busschbach, J., Buxton, M., Dolan, P., Kind, P., Krabbe, P., Ohinmaa, A., Parkin, D., Roset, M., Sintonen, H., Tsuchiya, A., de Charro, F.: A single European currency for EQ-5D health states. Results from a six-country study. Eur J Health Econ 4, 222–231 (2003)
Szende, A., Oppe, M., Devlin, N.: EQ-5D value sets: inventory. Comparative Review and User Guide. Springer, Dordrecht (2007)
Gudex, C., Dolan, P., Kind, P., Williams, A.: Health state valuations from the general public using the visual analogue scale. Qual Life Res 5, 521–531 (1996)
Nord, E.: EuroQol: health-related quality of life measurement. Valuations of health states by the general public in Norway. Health Policy 18, 25–36 (1991)
Brooks, R., Jendteg, S., Lindgren, B., Persson, U., Björk, S.: EuroQol: health-related quality of life measurement. Results of the Swedish questionnaire exercise. Health Policy 18, 37–48 (1991)
van Agt, H.M., Essink-Bot, M.L., Krabbe, P.F., Bonsel, G.J.: Test–retest reliability of health state valuations collected with the EuroQol questionnaire. Soc Sci Med (1982) 39, 1537–1544 (1994)
Badia, X., Fernandez, E., Segura, A.: Influence of socio-demographic and health status variables on evaluation of health states in a Spanish population. Eur J Pub Health 5, 87–93 (1995)
Kind, P., Dolan, P., Gudex, C., Williams, A.: Variations in population health status: results from a United Kingdom national questionnaire survey. Br Med J 316, 736–741 (1998)
Dolan, P., Kind, P.: Inconsistency and health state valuations. Soc Sci Med 42, 609–615 (1996)
O’Brien, B.J., Drummond, M.F.: Statistical versus quantitative significance in the socioeconomic evaluation of medicines. PharmacoEconomics 5–389 (1994)
Gudex, C., Dolan, P.: Valuing health states: the effect of duration. Discussion Paper (1995)
Dolan, P.: The effect of experience of illness on health state valuations. J Clin Epidemiol 49, 551–564 (1996)
Badia, X., Monserrat, S., Roset, M., Herdman, M.: Feasibility, validity and test–retest reliability of scaling methods for health states: the visual analogue scale and the time trade-off. Qual Life Res 8, 303–310 (1999)
Cleemput, I., Van Wilder, P., Vrijens, F., Huybrechts, M., Ramaekers, D.: Guidelines for Pharmacoeconomic Evaluations in Belgium. KCE Reports. Belgian Health Care Knowledge Centre (KCE), Bruxelles (2008)
Cleemput, I., van Wilder, P., Huybrechts, M., Vrijens, F.: Belgian Methodological Guidelines for Pharmacoeconomic Evaluations: Toward Standardization of Drug Reimbursement Requests. Value Health 2008; Early View (2008)
Acknowledgments
This research was part of my Ph.D. thesis some years ago. I wish to thank my supervisor Prof. Dr. Katrien Kesteloot for supporting me during the work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cleemput, I. A social preference valuations set for EQ-5D health states in Flanders, Belgium. Eur J Health Econ 11, 205–213 (2010). https://doi.org/10.1007/s10198-009-0167-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10198-009-0167-0